HBA-USA members that conduct research on "Pulmonary Disease"
- Acute & Chronic Lung Disease
Melpo Christofidou-Solomidou
University of Pennsylvania, Assistant professor
melpo@mail.med.upenn.edu
- Hypoxia & Pulmonary Hypertension
David G Kalergis
Diffusion Pharmaceuticals LLC, CEO
Developing novel small molecules for the treatment of hypoxia related to ischemic conditions
dkalergis@diffusionpharma.com
Stella Kourembanas
Children's Hospital Boston, Harvard Medical School, Clement A. Smith Associate Professor of Pediatrics
Lung vascular biology; Hypoxic signaling and pulmonary hypertension; Developmental lung biology
stella.kourembanas@ childrens.Harvard.edu
- Respiratory Distress Syndrome and Pediatric Lung Disease
Joanna Floros, PhD
Pennsylvania State University College of Medicine, Evan Pugh Professor of Pediatrics and Obstetrics & Gynecology, Director of The Penn State Center for Host
defense, Inflammation and Lung Disease (CHILD) Research
Study of the molecular basis of individual variability to disease susceptibility with special emphasis on molecules and mechanisms involved in host defense and
inflammation. Genome wide SNP analysis of several hundred candidate genes will be performed using the Illumina Infinium Platform.
jfloros@psu.edu
- Other
Maria Irene Kontaridis
Harvard/Beth Israel Deaconess Medical Center, Assistant Professor of Medicine
Understanding the signaling pathways that mediate cardiac developmental processes may reveal important clues into the cellular and molecular pathogenesis of heart
disease. Specifically, we want to understand how protein-tyrosine phosphatases (PTPs) relate to cardiac development and disease. Our lab's research efforts focus on
developmental biology, in vivo analysis of in mouse systems, including disease models, and cardiac biology and stem cell research using primary cultures. Currently,
we are studying mouse models in which we can assess the molecular pathogenesis of the cardiac defects associated with Noonan (NS) and LEOPARD (LS)
Syndromes, pediatric disorders both attributed primarily to mutations in Shp2, the SH2 domain-containing protein tyrosine phosphatase
mkontari@bidmc.harvard.edu
Stephanos Pavlides
Thomas Jefferson University, PhD candidate
Animal Science, Metabolic Diseases, Pulmonary Diseases, Cancer, Cardiovascular Disease, Muscle research, Pharmacology
spavlidescy@gmail.com
Eleni Vergadi
Children's Hospital Boston, Research Fellow in Pediatrics
Pulmonary Diseases, Molecular Genetics , Immunology
eleni.vergadi@childrens.harvard.ed
- Acute & Chronic Lung Disease
Melpo Christofidou-Solomidou
University of Pennsylvania, Assistant professor
melpo@mail.med.upenn.edu
- Hypoxia & Pulmonary Hypertension
David G Kalergis
Diffusion Pharmaceuticals LLC, CEO
Developing novel small molecules for the treatment of hypoxia related to ischemic conditions
dkalergis@diffusionpharma.com
Stella Kourembanas
Children's Hospital Boston, Harvard Medical School, Clement A. Smith Associate Professor of Pediatrics
Lung vascular biology; Hypoxic signaling and pulmonary hypertension; Developmental lung biology
stella.kourembanas@ childrens.Harvard.edu
- Respiratory Distress Syndrome and Pediatric Lung Disease
Joanna Floros, PhD
Pennsylvania State University College of Medicine, Evan Pugh Professor of Pediatrics and Obstetrics & Gynecology, Director of The Penn State Center for Host
defense, Inflammation and Lung Disease (CHILD) Research
Study of the molecular basis of individual variability to disease susceptibility with special emphasis on molecules and mechanisms involved in host defense and
inflammation. Genome wide SNP analysis of several hundred candidate genes will be performed using the Illumina Infinium Platform.
jfloros@psu.edu
- Other
Maria Irene Kontaridis
Harvard/Beth Israel Deaconess Medical Center, Assistant Professor of Medicine
Understanding the signaling pathways that mediate cardiac developmental processes may reveal important clues into the cellular and molecular pathogenesis of heart
disease. Specifically, we want to understand how protein-tyrosine phosphatases (PTPs) relate to cardiac development and disease. Our lab's research efforts focus on
developmental biology, in vivo analysis of in mouse systems, including disease models, and cardiac biology and stem cell research using primary cultures. Currently,
we are studying mouse models in which we can assess the molecular pathogenesis of the cardiac defects associated with Noonan (NS) and LEOPARD (LS)
Syndromes, pediatric disorders both attributed primarily to mutations in Shp2, the SH2 domain-containing protein tyrosine phosphatase
mkontari@bidmc.harvard.edu
Stephanos Pavlides
Thomas Jefferson University, PhD candidate
Animal Science, Metabolic Diseases, Pulmonary Diseases, Cancer, Cardiovascular Disease, Muscle research, Pharmacology
spavlidescy@gmail.com
Eleni Vergadi
Children's Hospital Boston, Research Fellow in Pediatrics
Pulmonary Diseases, Molecular Genetics , Immunology
eleni.vergadi@childrens.harvard.ed
Hellenic Bioscientific Association in the USA
HBA-USA
HBA-USA
 | |  | |  | |  | |  | |  | |  | |  | |  |